HTH-01-091 is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM. HTH-01-091 also inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 can be uesd for breast cancer research[1].
Molecular Weight:
499.43
Purity:
98.64
CAS Number:
[2000209-42-5]
Formula:
C26H28Cl2N4O2
Target:
CDK,DYRK,GSK-3,MELK,mTOR,Pim,RIP kinase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted